Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations, a rare brain cancer mainly affecting young people. The ...
Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular dystrophy (DMD), setting it on course to become the first non-steroidal ...
Congress's Haryana in-charge resigns after party's mega assembly polls defeat Offered to quit after poll defeat, says Congress Haryana in-charge Babaria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback